CN1766628A - 检测安定残留的酶联免疫试剂盒及方法 - Google Patents
检测安定残留的酶联免疫试剂盒及方法 Download PDFInfo
- Publication number
- CN1766628A CN1766628A CNA2005100867741A CN200510086774A CN1766628A CN 1766628 A CN1766628 A CN 1766628A CN A2005100867741 A CNA2005100867741 A CN A2005100867741A CN 200510086774 A CN200510086774 A CN 200510086774A CN 1766628 A CN1766628 A CN 1766628A
- Authority
- CN
- China
- Prior art keywords
- stable
- liquid
- kit
- antiantibody
- enzyme
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- AAOVKJBEBIDNHE-UHFFFAOYSA-N diazepam Chemical group N=1CC(=O)N(C)C2=CC=C(Cl)C=C2C=1C1=CC=CC=C1 AAOVKJBEBIDNHE-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 238000001514 detection method Methods 0.000 title description 9
- 238000008157 ELISA kit Methods 0.000 title 1
- 239000007788 liquid Substances 0.000 claims abstract description 64
- 102000004190 Enzymes Human genes 0.000 claims abstract description 46
- 108090000790 Enzymes Proteins 0.000 claims abstract description 46
- 238000000034 method Methods 0.000 claims abstract description 34
- 239000000427 antigen Substances 0.000 claims abstract description 29
- 102000036639 antigens Human genes 0.000 claims abstract description 29
- 108091007433 antigens Proteins 0.000 claims abstract description 29
- 239000000243 solution Substances 0.000 claims abstract description 26
- 241001465754 Metazoa Species 0.000 claims abstract description 18
- 239000012086 standard solution Substances 0.000 claims abstract description 17
- 238000004140 cleaning Methods 0.000 claims abstract description 11
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 25
- 238000002372 labelling Methods 0.000 claims description 23
- 239000008363 phosphate buffer Substances 0.000 claims description 18
- 108010001336 Horseradish Peroxidase Proteins 0.000 claims description 15
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000000872 buffer Substances 0.000 claims description 14
- 238000010790 dilution Methods 0.000 claims description 14
- 239000012895 dilution Substances 0.000 claims description 14
- 239000000758 substrate Substances 0.000 claims description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 12
- 238000012360 testing method Methods 0.000 claims description 12
- 230000001900 immune effect Effects 0.000 claims description 11
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 10
- 210000002966 serum Anatomy 0.000 claims description 10
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 9
- 239000011248 coating agent Substances 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 9
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 8
- 230000008878 coupling Effects 0.000 claims description 8
- 238000010168 coupling process Methods 0.000 claims description 8
- 238000005859 coupling reaction Methods 0.000 claims description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 7
- 239000003550 marker Substances 0.000 claims description 7
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 claims description 6
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims description 6
- 241001494479 Pecora Species 0.000 claims description 5
- 238000002203 pretreatment Methods 0.000 claims description 5
- YRNWIFYIFSBPAU-UHFFFAOYSA-N 4-[4-(dimethylamino)phenyl]-n,n-dimethylaniline Chemical compound C1=CC(N(C)C)=CC=C1C1=CC=C(N(C)C)C=C1 YRNWIFYIFSBPAU-UHFFFAOYSA-N 0.000 claims description 4
- 102000009027 Albumins Human genes 0.000 claims description 4
- 108010088751 Albumins Proteins 0.000 claims description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 4
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 4
- 241000894006 Bacteria Species 0.000 claims description 4
- 229960003529 diazepam Drugs 0.000 claims description 4
- NFJCQBGAUBIGKV-UHFFFAOYSA-N nitro dihydrogen phosphate Chemical compound OP(O)(=O)O[N+]([O-])=O NFJCQBGAUBIGKV-UHFFFAOYSA-N 0.000 claims description 4
- AQLJVWUFPCUVLO-UHFFFAOYSA-N urea hydrogen peroxide Chemical compound OO.NC(N)=O AQLJVWUFPCUVLO-UHFFFAOYSA-N 0.000 claims description 4
- 230000000087 stabilizing effect Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 230000006835 compression Effects 0.000 abstract 2
- 238000007906 compression Methods 0.000 abstract 2
- 239000000523 sample Substances 0.000 description 30
- 238000002835 absorbance Methods 0.000 description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 14
- 239000012530 fluid Substances 0.000 description 12
- 238000002360 preparation method Methods 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 10
- 238000011084 recovery Methods 0.000 description 9
- 238000002965 ELISA Methods 0.000 description 8
- 238000011534 incubation Methods 0.000 description 8
- 238000002156 mixing Methods 0.000 description 8
- 235000015277 pork Nutrition 0.000 description 8
- 238000004321 preservation Methods 0.000 description 8
- 235000011121 sodium hydroxide Nutrition 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 7
- 239000012488 sample solution Substances 0.000 description 7
- 238000013019 agitation Methods 0.000 description 6
- 210000004408 hybridoma Anatomy 0.000 description 6
- 230000003053 immunization Effects 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 6
- 206010003445 Ascites Diseases 0.000 description 5
- 230000002421 anti-septic effect Effects 0.000 description 5
- 244000309466 calf Species 0.000 description 5
- 238000004090 dissolution Methods 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 238000002649 immunization Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- 241000283705 Capra hircus Species 0.000 description 4
- 206010068676 Pneumoretroperitoneum Diseases 0.000 description 4
- 208000005727 Retropneumoperitoneum Diseases 0.000 description 4
- 239000002671 adjuvant Substances 0.000 description 4
- 239000007853 buffer solution Substances 0.000 description 4
- 238000010367 cloning Methods 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000000890 antigenic effect Effects 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- 230000001804 emulsifying effect Effects 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 230000002163 immunogen Effects 0.000 description 3
- 244000144972 livestock Species 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 244000144977 poultry Species 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000003252 repetitive effect Effects 0.000 description 3
- 238000007920 subcutaneous administration Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 108010078791 Carrier Proteins Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- 206010035226 Plasma cell myeloma Diseases 0.000 description 2
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 239000004411 aluminium Substances 0.000 description 2
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- 238000005138 cryopreservation Methods 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 229940126619 mouse monoclonal antibody Drugs 0.000 description 2
- 201000000050 myeloid neoplasm Diseases 0.000 description 2
- 239000003176 neuroleptic agent Substances 0.000 description 2
- 238000012856 packing Methods 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000007790 solid phase Substances 0.000 description 2
- 210000004989 spleen cell Anatomy 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 1
- 206010052804 Drug tolerance Diseases 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 206010048010 Withdrawal syndrome Diseases 0.000 description 1
- 210000000683 abdominal cavity Anatomy 0.000 description 1
- 238000012870 ammonium sulfate precipitation Methods 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 230000026781 habituation Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 239000000932 sedative agent Substances 0.000 description 1
- 230000001624 sedative effect Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Peptides Or Proteins (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | ||
CV% | 01批 | 5.9 | 5.8 | 6.1 | 6.8 | 7.4 | 8.2 | 6.4 | 5.6 | 9.0 | 8.6 |
03批06批 | 7.46.1 | 7.26.4 | 6.87.2 | 5.78.6 | 6.98.9 | 8.58.1 | 9.15.8 | 5.76.3 | 6.46.7 | 6.06.4 |
批号 | 实测值(μg/kg) | 变异系数CV% | ||||
010306 | 3.24.93.444.83.74.93.64.2 | 2.85.13.93.83.72.54.63.73.8 | 3.73.63.63.43.62.93.84.83.7 | 2.73.24.72.62.93.854.14.6 | 4.24.72.83.53.53.44.74.94.1 | 19.019.719.015.518.616.910.314.48.7 |
批号 | 实测值(μg/kg) | 变异系数CV% |
010306 | 4.1 | 5.2 | 3.9 | 4.6 | 3.7 | 14.1 |
3.53.45.25.04.63.83.84.6 | 3.83.94.74.13.73.63.43.8 | 3.64.14.33.83.43.74.63.5 | 4.24.63.83.73.94.24.24.9 | 4.83.84.63.14.64.93.93.7 | 13.311.111.417.613.413.211.314.9 |
样本 | 猪尿 | 猪肉 | |||
添加浓度(μg/kg) | 4 | 8 | 4 | 8 | |
回收率% | 1234 | 79.882.568.784.2 | 86.479.881.591.2 | 82.680.586.575.6 | 82.590.491.481.4 |
平均值 | 78.8 | 84.7 | 81.3 | 86.4 |
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100867741A CN100538363C (zh) | 2005-11-03 | 2005-11-03 | 检测安定残留的酶联免疫试剂盒及方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2005100867741A CN100538363C (zh) | 2005-11-03 | 2005-11-03 | 检测安定残留的酶联免疫试剂盒及方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1766628A true CN1766628A (zh) | 2006-05-03 |
CN100538363C CN100538363C (zh) | 2009-09-09 |
Family
ID=36742632
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2005100867741A Expired - Fee Related CN100538363C (zh) | 2005-11-03 | 2005-11-03 | 检测安定残留的酶联免疫试剂盒及方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100538363C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101936986A (zh) * | 2010-08-03 | 2011-01-05 | 中国农业大学 | 一种检测地西泮的方法及其专用化学发光免疫试剂盒 |
CN101071133B (zh) * | 2007-05-11 | 2011-05-11 | 江南大学 | 一种硝西泮人工抗原的制备方法 |
CN101101294B (zh) * | 2006-07-05 | 2011-07-13 | 上海华泰生物工程实业有限公司 | 酶联免疫体外诊断试剂中显色剂的制备 |
CN102401830A (zh) * | 2011-07-25 | 2012-04-04 | 伊犁出入境检验检疫局综合技术服务中心 | 一种食品防腐剂-乳酸链球菌素的酶联免疫检测方法 |
CN106370870A (zh) * | 2016-09-21 | 2017-02-01 | 中国农业大学 | 一种用于检测克伦特罗的试剂盒 |
-
2005
- 2005-11-03 CN CNB2005100867741A patent/CN100538363C/zh not_active Expired - Fee Related
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101101294B (zh) * | 2006-07-05 | 2011-07-13 | 上海华泰生物工程实业有限公司 | 酶联免疫体外诊断试剂中显色剂的制备 |
CN101071133B (zh) * | 2007-05-11 | 2011-05-11 | 江南大学 | 一种硝西泮人工抗原的制备方法 |
CN101936986A (zh) * | 2010-08-03 | 2011-01-05 | 中国农业大学 | 一种检测地西泮的方法及其专用化学发光免疫试剂盒 |
CN101936986B (zh) * | 2010-08-03 | 2013-03-06 | 中国农业大学 | 一种检测地西泮的方法及其专用化学发光免疫试剂盒 |
CN102401830A (zh) * | 2011-07-25 | 2012-04-04 | 伊犁出入境检验检疫局综合技术服务中心 | 一种食品防腐剂-乳酸链球菌素的酶联免疫检测方法 |
CN102401830B (zh) * | 2011-07-25 | 2014-03-12 | 伊犁出入境检验检疫局综合技术服务中心 | 一种食品防腐剂-乳酸链球菌素的酶联免疫检测方法 |
CN106370870A (zh) * | 2016-09-21 | 2017-02-01 | 中国农业大学 | 一种用于检测克伦特罗的试剂盒 |
Also Published As
Publication number | Publication date |
---|---|
CN100538363C (zh) | 2009-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1844926A (zh) | 检测苏丹红药物的酶联免疫试剂盒及方法 | |
CN1766624A (zh) | 检测呋喃唑酮代谢物的酶联免疫试剂盒及方法 | |
CN100344971C (zh) | 一种检测动物源性食品中磺胺类药物残留的酶联免疫试剂盒 | |
CN1766630A (zh) | 一种检测动物源性食品中莱克多巴胺的酶联免疫试剂盒 | |
CN1766617A (zh) | 检测β-兴奋剂类药物的酶联免疫试剂盒及其方法 | |
CN1766629A (zh) | 一种检测动物源性食品中氯霉素类药物的酶联免疫试剂盒 | |
CN1811443A (zh) | 一种检测19-去甲睾酮的方法及其专用酶联免疫试剂盒 | |
CN101013130A (zh) | 检测呋喃它酮代谢物的酶联免疫试剂盒及其应用 | |
CN101256188A (zh) | 检测林可霉素药物的酶联免疫试剂盒及其应用 | |
CN101021536B (zh) | 检测新霉素药物的酶联免疫试剂盒及方法 | |
CN101021535B (zh) | 检测庆大霉素药物的酶联免疫试剂盒及方法 | |
CN105044365B (zh) | 检测恩诺沙星残留的时间分辨荧光免疫分析试纸的制备方法 | |
CN1811436B (zh) | 一种检测恩诺沙星的方法及其专用酶联免疫试剂盒 | |
CN1766628A (zh) | 检测安定残留的酶联免疫试剂盒及方法 | |
CN107422112A (zh) | 一种检测乙氧酰胺苯甲酯的免疫试剂盒、制备方法及应用 | |
CN1766618A (zh) | 检测青霉素g的酶联免疫试剂盒及其方法 | |
CN1811437A (zh) | 一种检测磺胺喹噁啉的方法及其专用酶联免疫试剂盒 | |
CN1766625A (zh) | 检测阿维菌素类药物的酶联免疫试剂盒及方法 | |
CN1766633A (zh) | 检测已烯雌酚残留的酶联免疫试剂盒及方法 | |
CN1811442A (zh) | 一种检测泰乐菌素的方法及其专用酶联免疫试剂盒 | |
CN1766632A (zh) | 一种检测动物源性食品中氟喹酮类药物的酶联免疫试剂盒 | |
CN1811440A (zh) | 一种检测伊维菌素的方法及其专用酶联免疫试剂盒 | |
CN1766626A (zh) | 检测雌二醇的酶联免疫试剂盒及方法 | |
CN1811441A (zh) | 一种检测盐霉素的方法及其专用酶联免疫试剂盒 | |
CN1262839C (zh) | 一种检测磺胺二甲嘧啶的酶联免疫试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: JIUDINGYANG TECHNOLOGY( BEIJING ) CO., LTD. Free format text: FORMER OWNER: BEIJING WANGER BIOISYSTECH CO., LTD. Effective date: 20090807 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20090807 Address after: Beijing Changping District Huilongguan international information industry base hi tech 4 Street, No. 8 Patentee after: Jiudingyang Science and Technology (Beijing) Co.,Ltd. Address before: National veterinary drug safety evaluation center, West School of veterinary medicine, China Agricultural University, 2 West Road, Beijing, Haidian District, China Patentee before: Beijing Wanger Biotechnology Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: BEIJING WANGER BIOTECHNOLOGY CO., LTD. Free format text: FORMER OWNER: JIUDINGYANG TECHNOLOGY (BEIJING) CO., LTD. Effective date: 20100730 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20100730 Address after: 102206 Huilongguan international information industry base, Changping District, high street, No. 8, No. four, Beijing Patentee after: Beijing Wanger Biotechnology Co.,Ltd. Address before: 102206, 8, 4 hi tech street, Huilongguan international information industry base, Beijing, Changping District Patentee before: Jiudingyang Science and Technology (Beijing) Co.,Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: GUIZHOU QINBANG FOOD SAFETY SCIENCE AND TECHNOLOGY Free format text: FORMER OWNER: BEIJING WANGER BIOTECHNOLOGY CO., LTD. Effective date: 20130605 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 102206 CHANGPING, BEIJING TO: 550009 GUIYANG, GUIZHOU PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20130605 Address after: 550009, Guizhou province Guiyang Xiaohe Industrial Park standard factory building No. two, building 1, building 1-2 Patentee after: GUIZHOU KWINBON SCIENCE AND TECHNOLOGY FOR FOOD SAFETY Co.,Ltd. Address before: 102206 Huilongguan international information industry base, Changping District, high street, No. 8, No. four, Beijing Patentee before: Beijing Wanger Biotechnology Co.,Ltd. |
|
DD01 | Delivery of document by public notice |
Addressee: Tao Guangcan Document name: payment instructions |
|
DD01 | Delivery of document by public notice | ||
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090909 Termination date: 20211103 |